ProShares UltraShort Nasdaq Biotechnology (BIS)

NASDAQ: BIS · Real-Time Price · USD

8.63

+0.19 (2.23%)

At close: Apr 24, 2026, 4:00 PM EDT

8.68

+0.05 (0.60%)

After-hours: Apr 24, 2026, 5:59 PM EDT

2.23% (1D)

Assets	$2.24M
Expense Ratio	0.95%
PE Ratio	n/a
Shares Out	281,096
Dividend (ttm)	$0.43
Dividend Yield	5.02%
Ex-Dividend Date	Mar 25, 2026
Payout Frequency	Quarterly
Payout Ratio	n/a

Volume	39,213
Open	8.35
Previous Close	8.44
Day's Range	8.35 - 8.69
52-Week Low	7.95
52-Week High	21.14
Beta	-1.32
Holdings	6
Inception Date	Apr 8, 2010

About BIS

Fund Home Page

The ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity

Category Trading--Inverse Equity

Stock Exchange NASDAQ

Ticker Symbol BIS

ETF Provider ProShares

Index Tracked NASDAQ / Biotechnology

Top Holdings

-199.90% of assets

Name	Symbol	Weight
NET OTHER ASSETS (LIABILITIES)	n/a
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA	n/a	-32.83%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG	n/a	-38.18%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE	n/a	-41.10%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA	n/a	-43.04%
NASDAQ BIO INDEX SWAP BNP PARIBAS	n/a	-44.75%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Mar 25, 2026	$0.06857	Mar 31, 2026
Dec 24, 2025	$0.10257	Dec 31, 2025
Sep 24, 2025	$0.15427	Sep 30, 2025
Jun 25, 2025	$0.10805	Jul 1, 2025
Mar 26, 2025	$0.13255	Apr 1, 2025
Dec 23, 2024	$0.20639	Dec 31, 2024

Full Dividend History

Performance

BIS had a total return of -53.45% in the past year, including dividends. Since the fund's inception, the average annual return has been -32.09%.